-
Mashup Score: 7
npj Vaccines – Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
Source: www.nature.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 2330stats - 2 month(s) ago
The 2023-2024 fall and winter virus season, four years since the start of the COVID-19 pandemic, provided ongoing evidence of the changing face of respiratory diseases. COVID-19 remains an important public health threat, but it is no longer the emergency that it once was, and its health impacts increasingly resemble those of other respiratory viral illnesses, including influenza and RSV. This reality enables CDC to provide updated guidance proportionate to the current level of risk COVID-19 poses while
Source: www.cdc.govCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 1
Nature Communications – SARS-CoV-2 can be spread by aerosols. Here the authors show that between 50-60% of ambulatory COVID-19 patients exhale culturable virus and that this is associated with…
Source: www.nature.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 3Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T Cell Therapy Recipients with Pre-Cellular Therapy SARS-CoV-2 Infection - 2 month(s) ago
Hematopoietic cell transplant and chimeric antigen receptor T cell therapy recipients with SARS-CoV-2 infection shortly prior to cellular therapy experienced fr
Source: academic.oup.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 22Dispersion patterns of SARS-CoV-2 variants Gamma, Lambda and Mu in Latin America and the Caribbean - 2 month(s) ago
Nature Communications – Genomic surveillance has been important for tracking the evolution and spread of SARS-CoV-2. Here, the authors analyse ~300,000 SARS-CoV-2 genomes from two years of…
Source: www.nature.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 691Effectiveness of XBB.1.5 vaccines and antiviral drugs against severe outcomes of omicron infection in the USA - 2 month(s) ago
In the fall of 2023, the US Food and Drug Administration (FDA) authorised the use of the updated Moderna (Sept 11), Pfizer-BioNTech (Sept 11), and Novavax (Oct 3) COVID-19 vaccines containing a monovalent component of the XBB.1.5 variant “to provide better protection against serious consequences of COVID-19, including hospitalization and death”, with neither the FDA nor the companies providing clinical evidence.1–2 The National Institutes of Health Guidelines prefer ritonavir-boosted nirmatrelvir to molnupiravir for outpatient treatment of symptomatic patients with COVID-19 at high risk of progressing to severe disease.
Source: www.thelancet.comCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 691Effectiveness of XBB.1.5 vaccines and antiviral drugs against severe outcomes of omicron infection in the USA - 2 month(s) ago
In the fall of 2023, the US Food and Drug Administration (FDA) authorised the use of the updated Moderna (Sept 11), Pfizer-BioNTech (Sept 11), and Novavax (Oct 3) COVID-19 vaccines containing a monovalent component of the XBB.1.5 variant “to provide better protection against serious consequences of COVID-19, including hospitalization and death”, with neither the FDA nor the companies providing clinical evidence.1–2 The National Institutes of Health Guidelines prefer ritonavir-boosted nirmatrelvir to molnupiravir for outpatient treatment of symptomatic patients with COVID-19 at high risk of progressing to severe disease.
Source: www.thelancet.comCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 22Dispersion patterns of SARS-CoV-2 variants Gamma, Lambda and Mu in Latin America and the Caribbean - 2 month(s) ago
Nature Communications – Genomic surveillance has been important for tracking the evolution and spread of SARS-CoV-2. Here, the authors analyse ~300,000 SARS-CoV-2 genomes from two years of…
Source: www.nature.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 512COVID Data Tracker - 2 month(s) ago
CDC’s home for COVID-19 data. Visualizations, graphs, and data in one easy-to-use website.
Source: covid.cdc.govCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 6Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue - 2 month(s) ago
Nature Communications – Shi and Li et al. show that SARS-CoV-2 Omicron subvariants have increased capacity to infect primary human nasal tissue using a distinct entry route that depends on matrix…
Source: www.nature.comCategories: General Medicine News, General HCPsTweet
🔬 Researchers evaluated the immunogenicity and efficacy of different rationally designed lipid and polymeric-based nanoparticle prototypes against 😷 #SARSCoV2 infection. 👉 https://t.co/V1Uk9gF6mB https://t.co/WMFTx1yngc